Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-01

Clinical Trial Update: Effect of Semaglutide on the Psoriatic Lesions in Patients With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the effect of semaglutide on psoriatic lesions in adults with type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • semaglutide (semaglutide)

Snippet

Sponsor: University of Banja Luka | Conditions: Psoriasis Vulgaris, Diabetes Type 2 | Phase 4 | Status: COMPLETED